Understanding the Mortality Link: Polypharmacy in Heart Failure Polypharmacy, defined as the use of multiple medications, is common among patients with heart failure. A 2022 study found that polypharmacy is significantly associated with higher mortality, with a relative risk of 1.31 (95% CI 1.07–1.61). Notably, this risk appears most pronounced when multiple non-guideline-directed drugs are…